መነሻ › የክሮን በሽታ
በአሜሪካ ለየክሮን በሽታ ተሳታፊዎችን እየፈለጉ ያሉ ክሊኒካዊ ጥናቶች
ለየክሮን በሽታ የሚደረጉ 93 ጥናቶች በአሜሪካ ውስጥ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በጣም ብዙ ጥናቶች ያሏቸው ከተሞች
- New York City, NY35 ጥናቶች
- Cleveland, OH19 ጥናቶች
- St. Louis, MO19 ጥናቶች
- Boston, MA19 ጥናቶች
- Miami, FL19 ጥናቶች
- Orlando, FL17 ጥናቶች
- Houston, TX17 ጥናቶች
- Atlanta, GA17 ጥናቶች
- Tyler, TX16 ጥናቶች
- San Diego, CA15 ጥናቶች
- San Antonio, TX15 ጥናቶች
- Los Angeles, CA15 ጥናቶች
- Philadelphia, PA13 ጥናቶች
- Colorado Springs, CO13 ጥናቶች
- Durham, NC12 ጥናቶች
- Providence, RI12 ጥናቶች
- Tacoma, WA11 ጥናቶች
- Pittsburgh, PA11 ጥናቶች
- Seattle, WA11 ጥናቶች
- Cincinnati, OH11 ጥናቶች
- Baltimore, MD10 ጥናቶች
- Washington, DC10 ጥናቶች
- Indianapolis, IN10 ጥናቶች
- Dallas, TX10 ጥናቶች
- Lubbock, TX10 ጥናቶች
- Tampa, FL10 ጥናቶች
- Ann Arbor, MI9 ጥናቶች
- Louisville, KY9 ጥናቶች
- Chicago, IL9 ጥናቶች
- Evanston, IL9 ጥናቶች
- Lewisville, TX9 ጥናቶች
- Rochester, MN8 ጥናቶች
- Parma, OH8 ጥናቶች
- New Haven, CT8 ጥናቶች
- Columbus, OH8 ጥናቶች
- Charlotte, NC8 ጥናቶች
- Independence, MO8 ጥናቶች
- Milwaukee, WI7 ጥናቶች
- Lafayette, LA7 ጥናቶች
- Queens, NY7 ጥናቶች
በክልል
- New Jersey9 ጥናቶች
- New York36 ጥናቶች
- North Carolina20 ጥናቶች
- Ohio30 ጥናቶች
- Oklahoma8 ጥናቶች
- Oregon4 ጥናቶች
- Pennsylvania23 ጥናቶች
- Rhode Island12 ጥናቶች
- South Carolina11 ጥናቶች
- South Dakota4 ጥናቶች
- Tennessee10 ጥናቶች
- Texas35 ጥናቶች
- Utah8 ጥናቶች
- Virginia15 ጥናቶች
- Washington22 ጥናቶች
- Wisconsin7 ጥናቶች
- ሉዊዚያና11 ጥናቶች
- ሚሲሲፒ3 ጥናቶች
- ሚሺጋን20 ጥናቶች
- ሚኔሶታ11 ጥናቶች
- ሚዙሪ21 ጥናቶች
- ማሳቹሴትስ27 ጥናቶች
- ሜሪላንድ15 ጥናቶች
- ኒው ሃምፕሻየር3 ጥናቶች
- ኔቫዳ8 ጥናቶች
- አላባማ9 ጥናቶች
- አሪዞና17 ጥናቶች
- አርካንሳስ3 ጥናቶች
- አይዳሆ4 ጥናቶች
- አዮዋ8 ጥናቶች
- ኢሊኖይ18 ጥናቶች
- ኢንዲያና13 ጥናቶች
- ከንታኪ12 ጥናቶች
- ካሊፎርኒያ37 ጥናቶች
- ካንሳስ11 ጥናቶች
- ኮሎራዶ18 ጥናቶች
- ኮነቲከት14 ጥናቶች
- ዲስትሪክት ኦፍ ኮሎምቢያ4 ጥናቶች
- ጆርጂያ22 ጥናቶች
- ፍሎሪዳ27 ጥናቶች
በቅርብ ጊዜ የተዘመኑ ጥናቶች
Official study text (English)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07619547Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
ተሳታዮችን በመፈለግ ላይደረጃ 3
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ16 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07697456Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07033208Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07852273A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06581328Non-nutritive Sweeteners in Inflammatory Bowel Disease
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07769437A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07196722A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 3 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06663332A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06937099Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ16 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT07671872Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ16 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ16 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07184944A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 19 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT04844606A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06045754ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።